Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD

Zur Watchlist hinzufügen

6,81

-0,30

(-4,22%)

Börsenschluss: 04:00PM EDT

6,91

+0,10

(+1,47%)

Nachbörse:

06:02PM EDT

Hauptinhaber

Insider

Insider-Transaktionen

Währung in USD

Insider-Käufe (letzte 6 Monate)	Aktien	Trans
Käufe	232.291	5
Verkauf	420.663	1
Gekaufte Nettoaktien (verkauft)	-188.372	6
Insideraktien mit Beteiligung (gesamt)	1,16M	N/A
% Gekaufte Nettoaktien (verkauft)	-14,00%	N/A

Institutionelle Käufe (netto) der letzten Quartale	Aktien
Gekaufte Nettoaktien (verkauft)	N/A
% Schwankung in institutioneller Aktienbeteiligung	N/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

Insider	Transaktion	Typ	Wert	Datum	Aktien
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 6.01 per share.	Direkt	28.794	31. Mai 2024	4.791
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Sale at price 6.20 - 6.99 per share.	Indirekt	2.796.859	03. Apr. 2024	420.663
YOON SEOKHO BRYAN Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	23. Jan. 2024	68.750
VIGNOLA MARK J. Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	23. Jan. 2024	68.750
QUIGLEY JILL M. Officer and Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	23. Jan. 2024	15.000
QUIRK ERIN M.D. Officer	Stock Award(Grant) at price 0.00 per share.	Direkt	0	23. Jan. 2024	75.000
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 3.78 per share.	Direkt	2.809	30. Nov. 2023	743
QUIGLEY JILL M. Officer and Director	Stock Award(Grant) at price 0.00 per share.	Direkt	0	15. Nov. 2023	15.000
SUNDARAM SENTHIL VEL Chief Executive Officer	Purchase at price 10.61 per share.	Direkt	22.398	31. Mai 2023	2.111
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 10.61 per share.	Direkt	106.068	31. Mai 2023	9.997
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirekt	1.000.000	23. Dez. 2022	137.931
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirekt	1.000.000	23. Dez. 2022	137.931
LU HONGBO B Director	Purchase at price 7.25 per share.	Indirekt	5.499.995	23. Dez. 2022	758.620
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.25 per share.	Indirekt	5.499.995	23. Dez. 2022	758.620
SUNDARAM SENTHIL VEL Chief Executive Officer	Purchase at price 7.77 per share.	Direkt	23	30. Nov. 2022	3
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 7.77 per share.	Direkt	23	30. Nov. 2022	3
VIGNOLA MARK J. Chief Financial Officer	Purchase at price 7.77 per share.	Direkt	23	30. Nov. 2022	3
LAV BIOSCIENCES FUND V LP Beneficial Owner of more than 10% of a Class of Security	Sale at price 5.50 per share.	Indirekt	8.250.000	23. Nov. 2022	1.500.000
LU HONGBO B Director	Purchase at price 3.60 per share.	Indirekt	2.160.000	07. Sept. 2022	600.000
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.60 per share.	Indirekt	2.160.000	07. Sept. 2022	600.000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirekt	18.376.200	16. Aug. 2022	3.690.000
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.98 per share.	Indirekt	18.376.200	16. Aug. 2022	3.690.000
LU HONGBO B Director	Purchase at price 2.98 - 4.98 per share.	Indirekt	10.821.962	16. Aug. 2022	2.624.239
VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.98 - 4.98 per share.	Indirekt	10.821.962	16. Aug. 2022	2.624.239
YOON SEOKHO BRYAN Chief Operating Officer	Purchase at price 1.47 per share.	Direkt	11.254	31. Mai 2022	7.656
VIGNOLA MARK J. Chief Financial Officer	Purchase at price 1.47 per share.	Direkt	11.254	31. Mai 2022	7.656
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirekt	8.075.000	09. Feb. 2021	475.000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security		Indirekt		09. Feb. 2021	3.316.204
VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirekt	8.075.000	09. Feb. 2021	475.000
VIVO CAPITAL VIII, L.L.C. Beneficial Owner of more than 10% of a Class of Security		Indirekt		09. Feb. 2021	2.200.133
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirekt	8.075.000	09. Feb. 2021	475.000
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security		Indirekt		09. Feb. 2021	3.316.204
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirekt	11.305.000	09. Feb. 2021	665.000
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security		Indirekt		09. Feb. 2021	1.717.033
LAV BIOSCIENCES FUND V LP Beneficial Owner of more than 10% of a Class of Security		Indirekt		09. Feb. 2021	4.781.566

DAX18.235,45+24,85(+0,14%)

Euro Stoxx 504.894,02-8,58(-0,18%)

Dow Jones 3039.118,86-45,24(-0,12%)

Gold2.336,90+0,30(+0,01%)

EUR/USD1,0716+0,0007(+0,06%)

Bitcoin EUR57.531,80+675,88(+1,19%)

Terns Pharmaceuticals, Inc. (TERN)

Insider-Transaktionen

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

DAX
18.235,45
+24,85(+0,14%)

Euro Stoxx 50
4.894,02
-8,58(-0,18%)

Dow Jones 30
39.118,86
-45,24(-0,12%)

Gold
2.336,90
+0,30(+0,01%)

EUR/USD
1,0716
+0,0007(+0,06%)

Bitcoin EUR
57.531,80
+675,88(+1,19%)